RESUMEN
This study mainly aims at examining the erythrocyte membrane fatty acid (FAs) profile in Rett syndrome (RTT), a genetically determined neurodevelopmental disease. Early reports suggest a beneficial effects of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) on disease severity in RTT. A total of 24 RTT patients were assigned to ω-3 PUFAs-containing fish oil for 12 months in a randomized controlled study (average DHA and EPA doses of 72.9, and 117.1mg/kgb.w./day, respectively). A distinctly altered FAs profile was detectable in RTT, with deficient ω-6 PUFAs, increased saturated FAs and reduced trans 20:4 FAs. FAs changes were found to be related to redox imbalance, subclinical inflammation, and decreased bone density. Supplementation with ω-3 PUFAs led to improved ω-6/ω-3 ratio and serum plasma lipid profile, decreased PUFAs peroxidation end-products, normalization of biochemical markers of inflammation, and reduction of bone hypodensity as compared to the untreated RTT group. Our data indicate that a significant FAs abnormality is detectable in the RTT erythrocyte membranes and is partially rescued by ω-3 PUFAs.
Asunto(s)
Suplementos Dietéticos , Membrana Eritrocítica/metabolismo , Ácidos Grasos Omega-3/administración & dosificación , Síndrome de Rett/metabolismo , Adolescente , Adulto , Animales , Biomarcadores/sangre , Niño , Preescolar , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/metabolismo , Ácido Eicosapentaenoico/administración & dosificación , Ácido Eicosapentaenoico/metabolismo , Membrana Eritrocítica/efectos de los fármacos , Membrana Eritrocítica/patología , Ácidos Grasos Omega-3/metabolismo , Femenino , Humanos , Inflamación/metabolismo , Inflamación/patología , Isoprostanos/sangre , Lípidos/sangre , Síndrome de Rett/dietoterapia , Síndrome de Rett/patologíaRESUMEN
Rett syndrome is a neurodevelopmental disorder in girls, related to mutations in MECP2 gene. It has been postulated that low 5-methyltetrahydrofolate (5-MTHF) levels are present in cerebrospinal fluid. Folinic acid demonstrated clinical improvement. However, because studies have produced conflicting results, we performed a randomized, double-blind crossover, long-term, follow-up study on folinic acid. Eight Rett syndrome patients received both folinic acid and placebo, for 1 year each. Measurements included plasma folate, 5-MTHF, and clinical outcome scores like Rett Syndrome Motor Behavioral Assessment, Hand Apraxia Scale, and the parental Overall Well-Being Index. In 2 patients, low 5-MTHF levels were present. Folinic acid supplementation increased cerebrospinal fluid 5-MTHF levels, but with no objective evidence of clinical improvement. The Overall Well-Being Index showed a significant difference in favor of folinic acid, not confirmed objectively. In our double-blind randomized study, folinic acid supplementation resulted in increased 5-MTHF levels, but with no objective signs of clinical improvement.
Asunto(s)
Suplementos Dietéticos , Leucovorina/administración & dosificación , Síndrome de Rett/dietoterapia , Adolescente , Adulto , Niño , Preescolar , Estudios Cruzados , Método Doble Ciego , Femenino , Ácido Fólico/sangre , Humanos , Modelos Lineales , Estudios Longitudinales , Proteína 2 de Unión a Metil-CpG/genética , Mutación/genética , Examen Neurológico , Síndrome de Rett/líquido cefalorraquídeo , Síndrome de Rett/genética , Tetrahidrofolatos/sangre , Tetrahidrofolatos/líquido cefalorraquídeo , Factores de Tiempo , Resultado del Tratamiento , Adulto JovenRESUMEN
We studied the long-term effects of a postnatal choline supplementation (from birth till weaning) in the truncated MeCP2-308 mouse model of Rett syndrome. Adult male mutant hemizygous (hz) mice showed a reduction of locomotor activity compared to wild type (wt) littermates. Early choline treatment restored wt-like locomotor activity levels in hz mice. Reduced striatal choline acetyl transferase (ChAT) activity and decreased levels of cortical mRNA NGF were found in hz mice. Choline supplementation increased striatal ChAT activity and also enhanced NGF and BDNF expression in cortical and hippocampal regions. As a whole, postnatal choline supplementation attenuates some of the behavioural and neurobiological abnormalities of the Mecp2-308 phenotype.
Asunto(s)
Colina/uso terapéutico , Fibras Colinérgicas/efectos de los fármacos , Suplementos Dietéticos , Síndrome de Rett/dietoterapia , Síndrome de Rett/psicología , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Colina/administración & dosificación , Colina/farmacología , Colina O-Acetiltransferasa/metabolismo , Fibras Colinérgicas/fisiología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Modelos Animales de Enfermedad , Conducta Exploratoria/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Proteína 2 de Unión a Metil-CpG/genética , Ratones , Ratones Mutantes , Actividad Motora/efectos de los fármacos , Factor de Crecimiento Nervioso/metabolismo , Síndrome de Rett/metabolismo , Síndrome de Rett/fisiopatología , Escopolamina/farmacologíaRESUMEN
Environmental factors such as nutrition and housing can influence behavioral and anatomical characteristics of several neurological disorders, including Rett syndrome (RTT). RTT is associated with mutations in the X-linked gene encoding MeCP2, a transcriptional repressor that binds methylated DNA. While direct genetic intervention in humans is impossible at this time, motor and cognitive deficits in RTT may be ameliorated through manipulations of epigenetic/environmental factors. For example, studies in rodents suggest that choline nutrient supplementation during critical periods of brain development enhances cholinergic neurotransmission, alters neuronal size and distribution, and facilitates performance of memory and motoric tasks. Recent work in a mouse model of RTT shows that enhancing maternal nutrition through choline supplementation improves both anatomical and behavioral symptoms in the mutant offspring. We describe here cellular and molecular mechanisms that may underlie this specific enhancement and may provide more general insights into mechanisms underlying gene-environment interactions in neurological disorders.
Asunto(s)
Modelos Animales de Enfermedad , Fenómenos Fisiológicos de la Nutrición/fisiología , Síndrome de Rett , Acetilcolina/metabolismo , Animales , Encéfalo/crecimiento & desarrollo , Encéfalo/patología , Colina/metabolismo , Metilación de ADN/efectos de los fármacos , Metilación de ADN/fisiología , Genes Ligados a X , Humanos , Proteína 2 de Unión a Metil-CpG/genética , Ratones , Mutación , Neuronas/patología , Síndrome de Rett/dietoterapia , Síndrome de Rett/genética , Síndrome de Rett/metabolismo , Transducción de Señal/genéticaRESUMEN
Rett syndrome (RTT), the second leading cause of mental retardation in girls, is caused by mutations in the X-linked gene for methyl-CpG-binding protein 2 (MeCP2), a transcriptional repressor. In addition to well-documented neuroanatomical and behavioral deficits, RTT is characterized by reduced markers of cholinergic activity and general neuronal health. Previously, we have shown that early postnatal choline (Cho) supplementation improves behavioral and neuroanatomical symptoms in a mouse model of RTT (Mecp2(1lox) mice). In this study, we use NMR spectroscopy to quantify the relative amounts of Cho, Glutamate (Glu), Glutamine (Gln), and N-acetyl aspartate (NAA) in the brains of wild type and mutant mice at 21, 35, and 42 days of age and in mice receiving postnatal Cho supplementation. We find that the mutant mice have reduced levels of Cho, Glu, and NAA, but elevated Gln levels, compared with their wild type littermates. These differences emerge at different developmental ages. Cho supplementation increases NAA levels, a marker of neuronal integrity, but has no effect on Cho, Glu, or Gln. These data suggest that postnatal nutritional supplementation may improve neuronal function and could serve as a therapeutic agent for human RTT patients.
Asunto(s)
Encéfalo/efectos de los fármacos , Colina/administración & dosificación , Suplementos Dietéticos , Nootrópicos/administración & dosificación , Síndrome de Rett/metabolismo , Factores de Edad , Animales , Animales Recién Nacidos , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Colina/metabolismo , Creatina/metabolismo , Proteínas de Unión al ADN/genética , Modelos Animales de Enfermedad , Ácido Glutámico/metabolismo , Glutamina/metabolismo , Histona Desacetilasas/genética , Espectroscopía de Resonancia Magnética/métodos , Masculino , Ratones , Ratones Endogámicos C57BL , Síndrome de Rett/dietoterapia , Síndrome de Rett/genética , Síndrome de Rett/patología , Análisis EspectralRESUMEN
Nutritional status during pregnancy and lactation can influence behavioral and anatomical characteristics of several neurological disorders in the offspring, including Rett syndrome (RTT). RTT is associated with mutations in the X-linked gene encoding methyl-CpG binding protein 2 (MeCp2), a transcriptional repressor that binds methylated DNA. In Mecp2(1lox) mice, a model of RTT, enhancing maternal nutrition through choline supplementation attenuates motor coordination deficits in the mutant offspring. Here, we examine alterations in brain volume and growth factor expression in the cerebellum and striatum, motor regions that may contribute to the improved behavioral performance seen with choline supplementation. Mecp2(1lox) dams were given choline in drinking water, and pups nursed from birth to weaning. Brains of male offspring were collected at postnatal day 42 for volumetric and growth factor expression analyses. Compared to wild-type mice, Mecp2(1lox) null mice had decreased whole brain, cerebellar and striatal volume. Choline supplementation had no effect on brain volume. Nerve growth factor and insulin-like growth factor-1 expression was similar between wild-type and Mecp2(1lox) mice while brain derived neurotrophic factor was reduced in Mecp2(1lox) mice. Choline supplementation increased striatal nerve growth factor expression in wild-type and Mecp2(1lox) mice, suggesting that neuronal proliferation and survival may contribute to improved motor performance in this model of RTT.
Asunto(s)
Encéfalo/patología , Colina/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Factores de Crecimiento Nervioso/metabolismo , Nootrópicos/administración & dosificación , Síndrome de Rett , Animales , Animales Recién Nacidos , Conducta Animal , Encéfalo/efectos de los fármacos , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática/métodos , Regulación de la Expresión Génica/genética , Masculino , Proteína 2 de Unión a Metil-CpG/deficiencia , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Síndrome de Rett/dietoterapia , Síndrome de Rett/genética , Síndrome de Rett/patologíaRESUMEN
The aim of the present study was to determine and compare plasma and erythrocyte concentrations of magnesium in 12 autistic children (10 boys, 2 girls), 17 children with other autistic spectrum disorders (14 boys, 3 girls), 5 girls with classic Rett syndrome, and 14 normal children (7 boys, 7 girls) of the same age. No differences in intracellular Mg were found between controls and pathological subjects; however, autistic children and children with other autistic spectrum disorders had significantly lower plasma concentrations of Mg than normal subjects (p=0.013 and p=0.02, respectively). Although our study population was small, we conclude that children with autistic spectrum disorders require special dietary management. If these cases are diagnosed at an early stage, they can be helped through diet.